Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Nalbuphine vs Fentanyl in Cardiac Surgery
NCT07435337Phase 4Recruiting
- Sponsor
- Rawalpindi Institute of Cardiology
- Start
- Feb 2026
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of nalbuphine, fentanyl, sponsored by Rawalpindi Institute of Cardiology. Started Feb 2026; status: recruiting.
02
Drugs
nalbuphinefentanyl
Beyond the preview
Go deeper on NCT07435337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435337.